For Immediate Release
Contact:
Erin Baker, Director of Communications and Member Services, 202.966.7300 ext. 119 ebaker@aacap.org
Adam Lowe, Communications Coordinator, 202.966.7300 ext. 154 alowe@aacap.org
Washington, D.C., January 15, 2009 - The AACAP's 2009 Psychopharmacology Update Institute, Child and Adolescent Psychopharmacology: Evidence-Based Treatments and Beyond, chaired by Gabrielle Carlson, M.D., will take place January 23-24 at the Sheraton New York Hotel and Towers in New York, New York. The goal of the 2009 Psychopharmacology Update Institute is to update the latest evidence-based treatments for major child psychiatric disorders and discuss current thinking about effectiveness and possibilities for treatment when there is no evidence base.
"Children with serious psychiatric disorders are increasingly complex. The experts convened for this Institute have as their goal not only a review of the evidence base of important conditions, but also how to approach situations where the evidence-based treatments don't work," says Institute Chair Dr. Gabrielle Carlson.
Evidence-based psychopharmacologic treatments for serious psychiatric disorders in children and adolescents have grown considerably in the past decade. The evidence-base is comprised of studies that describe both treatments that work, and also the cost of using them.
The AACAP 2009 January Psychopharmacology Update Institute faculty includes:
- Gabrielle A. Carlson, M.D., Chair, Professor of Psychiatry and Pediatrics and Director of Child and Adolescent Psychiatry, Stony
- Laurence L. Greenhill, M.D., AACAP President-Elect, Ruane Professor of Clinical Psychiatry at Columbia University Research, Director, Research Unit of Pediatric Psychopharmacology - Psychosocial Intervention, New York State Psychiatric Institute
- Boris Birmaher, M.D., Endowed Chair in Early Onset Bipolar Disease and Professor of Psychiatry,
- Harold E. Carlson, M.D., Professor of Medicine, Division Head, Endocrinology and Metabolism, Stony Brook University
- John T. Walkup, M.D., Associate Professor, Department of Psychiatry and Behavioral Sciences, Johns
- Barbara J. Coffey, M.D., M.S., Associate Professor, Department of Psychiatry
- Christoph U. Correll, M.D., Associate Professor of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Medical Director, Recognition and Prevention Program, The Zucker Hillside Hospital
Selected topics include:
- Update on the Treatment of Children and Adolescents with ADHD by Laurence L. Greenhill, M.D.
- Tics, Tourette’s and Related Problems: Evidence Base and Beyond by Barbara J. Coffey, M.D., M.S.
- From the Brain to the Bed Side: Using Knowledge About Pharmacology to Improve Antipsychotic Treatment Outcomes in Youths by
- Genetics and Pharmacogenomics in Every Day Practice by
- Treatment of Childhood Anxiety Disorders: The Evidence Base and Beyond by John T. Walkup, M.D.
- Treatment of Major Depression in Children and Adolescents: Evidence-Based Treatments and Beyond by Boris Birmaher, M.D.
- Endocrine Complications of Psychotropic Medications: What To Do Until the Data Arrive by Harold E. Carlson, M.D.
- What Works in Early Onset Mania and What To Do When It Doesn’t Work by Gabrielle A. Carlson, M.D.
Additionally, several panel discussions will take place throughout the two-day event.
This course is one in a continuing medical education series under the direction of the AACAP’s Institutes Subcommittee. The AACAP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education.
Attendance to the 2009 Psychopharmacology Update Institute is free for journalists, although prior registration and appropriate credentials are required. To register, contact Adam Lowe, AACAP Communications Coordinator at 202.966.7300, ext. 154 or alowe@aacap.org. To view a preliminary program, click here.
###
Representing over 7,500 child and adolescent psychiatrists nationwide, the
